1 active not recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Active not recruiting 1 |
Follow Marcel Curlin: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COVID-19 Reactogenicity Nuvaxovid (NVX-CoV2705), mNEXSPIKE mRNA-1283 - COVID-19 | Phase 4 | Active not recruiting | Marcel Curlin | 1000 | 2025-10-01 | 2026-03-04 |
COVID-19 (1)
NVX-CoV2373 adjuvated lipid nanoparticle (1)
United States (1)